- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Huge Earnings Growth
U.S. Pharmaceuticals & Biotech Huge Earnings Growth
UPDATED Aug 14, 2022
Companies which grew earnings more than 50% in the last year.
38 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CDMOAvid Bioservices | US$19.69 | 1.7% | -21.5% | US$1.2b | US$26.67 | PE9.5x | E-57.2% | n/a | ||
| SHCSotera Health | US$20.01 | 8.0% | -18.0% | US$5.7b | US$24.57 | PE46x | E32.9% | n/a | ||
| AMPHAmphastar Pharmaceuticals | US$31.62 | -14.0% | 61.3% | US$1.5b | US$41.33 | PE17x | S6.2% | n/a | ||
| KDCEKid Castle Educational | US$0.043 | 37.9% | n/a | US$957.7k | n/a | PE0.4x | n/a | n/a | ||
| MRKMerck | US$91.02 | 4.1% | 18.6% | US$230.6b | US$100.14 | PE13.9x | E10.2% | 3.0% | ||
| MRNAModerna | US$171.18 | -8.4% | -56.1% | US$67.0b | US$214.00 | PE4.8x | E-39.1% | n/a | ||
| HRMYHarmony Biosciences Holdings | US$52.15 | -0.7% | 62.2% | US$3.1b | US$61.50 | PE53.1x | E44.6% | n/a | ||
| BNTXBioNTech | US$160.35 | -12.4% | -57.5% | US$39.0b | US$230.60 | PE3.2x | E-40.3% | n/a | ||
| INCYIncyte | US$73.99 | 2.5% | 0.7% | US$16.5b | US$88.71 | PE17.4x | E30.0% | n/a | ||
| PFEPfizer | US$50.11 | 1.7% | 3.4% | US$281.2b | US$56.53 | PE9.5x | E-14.5% | 3.2% | ||
| AVTRAvantor | US$28.56 | 0.03% | -26.0% | US$19.3b | US$37.53 | PE33.6x | E21.6% | n/a | ||
| PRTAProthena | US$32.19 | -2.8% | -44.9% | US$1.5b | US$66.63 | PS10.6x | E9.2% | n/a | ||
| GBLXGB Sciences | US$0.027 | -4.2% | -36.4% | US$8.9m | n/a | PE-104x | n/a | n/a | ||
| MRVIMaravai LifeSciences Holdings | US$26.60 | -1.0% | -53.9% | US$6.8b | US$35.75 | PE14.1x | E-6.1% | n/a | ||
| TECHBio-Techne | US$379.65 | -0.9% | -18.7% | US$14.9b | US$473.91 | PE54.8x | E10.8% | 0.3% | ||
| CLSDClearside Biomedical | US$1.59 | -4.8% | -72.1% | US$95.7m | US$7.50 | PS3.2x | E-10.2% | n/a | ||
| RASPRasna Therapeutics | US$0.011 | 0% | -63.0% | US$2.0m | n/a | PE-4.8x | n/a | n/a | ||
| IQVIQVIA Holdings | US$245.81 | 4.7% | -0.9% | US$45.8b | US$267.72 | PE39.5x | E18.5% | 0% | ||
| PARN.FParnell Pharmaceuticals Holdings | US$0.0023 | 0% | -98.9% | US$68.1k | n/a | PE-0.07x | n/a | n/a | ||
| ABBVAbbVie | US$142.60 | 3.3% | 22.4% | US$252.1b | US$159.57 | PE20.1x | E0.3% | 4.0% | ||
| BSPKBespoke Extracts | US$0.013 | -26.5% | -16.1% | US$5.4m | n/a | PS625x | n/a | n/a | ||
| ACANAmeriCann | US$0.35 | 1.3% | -61.5% | US$8.6m | n/a | PS3.3x | n/a | n/a | ||
| TEVATeva Pharmaceutical Industries | US$11.21 | 4.9% | 14.0% | US$12.4b | US$10.56 | PB1.4x | E55.5% | 0% | ||
| BXRXBaudax Bio | US$0.75 | 1.2% | -95.9% | US$6.1m | US$3.25 | PS4.3x | E65.0% | n/a |